February 24, 2018 |
MERS-CoV Infection: Interim Guidance for Health Professionals
May 19, 2014  | 

Atlanta, GA - Healthcare professionals should evaluate for MERS-CoV infection, patients in the U.S. who meet the following criteria:

  • Fever and pneumonia or acute respiratory distress syndrome (based on clinical or radiologic evidence) AND EITHER:
    • history of travel from countries in or near the Arabian Peninsula within 14 days before symptom onset OR
    • close contact2 with a symptomatic traveler who developed fever and acute respiratory illness (not necessarily pneumonia) within 14 days after traveling from countries in or near the Arabian Peninsula) OR
    • is a member of a cluster of patients with severe acute respiratory illness (e.g., fever and pneumonia requiring hospitalization) of unknown etiology in which MERS-CoV is being evaluated in consultation with state or local health department (more details below).
  • Close contact of a confirmed or probable case of MERS (more details below).

Patients with lower respiratory illness should also be evaluated for common causes of community-acquired pneumonia, guided by clinical presentation and epidemiologic and surveillance information. For these patients, testing for MERS-CoV and other respiratory pathogens can be done simultaneously. Positive results for another respiratory pathogen (e.g., influenza) should not necessarily preclude testing for MERS-CoV because co-infection can occur.

Evaluation and Management of Close Contacts Continue>

Page | 1 2 3 4
Suggested Articles